Skip to Content

TL 385 TL 385 (Terazosin Hydrochloride 5 mg)

Pill with imprint TL 385 TL 385 is Orange, Capsule-shape and has been identified as Terazosin Hydrochloride 5 mg. It is supplied by Cadista.

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TL 385 TL 385

Terazosin hydrochloride 5 mg TL 385 TL 385
Terazosin hydrochloride 5 mg TL 385 TL 385
Terazosin hydrochloride 5 mg TL 385 TL 385

Terazosin Hydrochloride

Imprint
TL 385 TL 385
Strength
5 mg
Color
Orange
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antiadrenergic agents, peripherally acting
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cadista
Inactive Ingredients
gelatin, lactose monohydrate, magnesium stearate, sodium lauryl sulfate, titanium dioxide, corn starch, silicon dioxide, D&C Yellow No. 10, D&C Red No. 28, FD&C Red No. 40

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
59746-0385 Jubilant Cadista Pharmaceuticals Inc.
67544-0563 Prepak Systems Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.